Core Insights - Gates Industrial (GTES) reported revenue of $847.6 million for Q1 2025, a year-over-year decline of 1.7%, with an EPS of $0.36 compared to $0.31 a year ago [1] - The revenue exceeded the Zacks Consensus Estimate of $826.29 million, resulting in a surprise of +2.58%, while the EPS also surpassed the consensus estimate of $0.33 by +9.09% [1] Financial Performance - Net Sales in Fluid Power amounted to $320.40 million, slightly below the two-analyst average estimate of $321.85 million, reflecting a year-over-year change of -2.9% [4] - Net Sales in Power Transmission reached $527.20 million, exceeding the two-analyst average estimate of $504.44 million, with a year-over-year change of -1.1% [4] - Adjusted EBITDA for Fluid Power was reported at $70.60 million, below the average estimate of $72.10 million [4] - Adjusted EBITDA for Power Transmission was $116.70 million, surpassing the average estimate of $109.91 million [4] Stock Performance - Gates Industrial shares have returned -3.2% over the past month, compared to a -0.2% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]

Core Insights - Navient (NAVI) reported revenue of $144 million for the quarter ended March 2025, reflecting an 11.7% decrease year-over-year, while EPS was $0.28 compared to $0.63 in the same quarter last year [1] - The reported revenue exceeded the Zacks Consensus Estimate of $134.11 million by 7.38%, and the EPS surpassed the consensus estimate of $0.19 by 47.37% [1] Financial Performance Metrics - Net interest margin for the Consumer Lending segment was 2.8%, matching the average estimate [4] - Net interest margin for the Federal Education Loan segment was 0.6%, slightly above the average estimate of 0.5% [4] - Servicing revenue reached $13 million, significantly higher than the estimated $4.75 million [4] - Asset recovery and business processing revenue was $23 million, slightly above the average estimate of $22.95 million [4] - Net Interest Income (Core) was reported at $144 million, exceeding the estimate of $140.44 million [4] - Net interest income (loss) for Consumer Lending (Core) was $113 million, above the estimate of $110.97 million [4] - Net interest income (loss) for Other (Core) was -$18 million, worse than the average estimate of -$11.33 million [4] - Total core other income for Federal Education Loans was $10 million, significantly higher than the estimate of $3.73 million [4] - Net interest income (loss) for Federal Education Loans (Core) was $49 million, surpassing the estimate of $35.03 million [4] - Total core other income for Consumer Lending was $3 million, above the estimate of $0.77 million [4] - Total core other income for Other was $15 million, exceeding the average estimate of $13 million [4] - Total Non Interest Income (Core) was $51 million, higher than the estimate of $42.15 million [4] Stock Performance - Navient's shares returned +0.6% over the past month, outperforming the Zacks S&P 500 composite, which declined by -0.2% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market in the near term [3]

Core Insights - United Therapeutics reported $794.4 million in revenue for Q1 2025, a 17.2% increase year-over-year, with an EPS of $6.63 compared to $6.17 a year ago [1] - The revenue exceeded the Zacks Consensus Estimate of $726.19 million by 9.39%, and the EPS also surpassed the consensus estimate of $6.29 by 5.41% [1] Revenue Breakdown - U.S. Revenues: $749.60 million, exceeding the average estimate of $695.02 million, representing a 16.9% year-over-year increase [4] - Rest-of-World Revenues: $44.80 million, surpassing the average estimate of $27.05 million, reflecting a 23.8% year-over-year increase [4] - Tyvaso Revenue in the U.S.: $441.10 million, compared to the average estimate of $405.30 million [4] - Remodulin Revenue in the U.S.: $120.20 million, exceeding the average estimate of $113.15 million [4] - Adcirca Revenue: $6 million, below the average estimate of $4.77 million, showing a 6.3% decrease year-over-year [4] - Orenitram Revenue: $120.70 million, surpassing the average estimate of $111.47 million, with a 13.7% year-over-year increase [4] - Tyvaso Revenue: $466.30 million, exceeding the average estimate of $413.63 million, with a remarkable 105% year-over-year increase [4] - Remodulin Revenue: $138.20 million, above the average estimate of $126.42 million, reflecting an 8% year-over-year increase [4] - Unituxin Revenue: $58.20 million, below the average estimate of $62.95 million, showing a 0.3% decrease year-over-year [4] - Tyvaso DPI Revenue: $302.50 million, exceeding the average estimate of $271.57 million [4] - Nebulized Tyvaso Revenue: $163.80 million, surpassing the average estimate of $137.44 million [4] - Other Products Revenue: $5 million, below the average estimate of $5.68 million, reflecting a 19.4% decrease year-over-year [4] Stock Performance - Shares of United Therapeutics have returned -2% over the past month, compared to the Zacks S&P 500 composite's -0.2% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]

Humana (HUM) reported $32.11 billion in revenue for the quarter ended March 2025, representing a year-over-year increase of 9.5%. EPS of $11.58 for the same period compares to $7.23 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $32.22 billion, representing a surprise of -0.33%. The company delivered an EPS surprise of +16.03%, with the consensus EPS estimate being $9.98.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how t ...

Core Insights - Clean Harbors reported revenue of $1.43 billion for the quarter ended March 2025, a year-over-year increase of 4% [1] - The company's EPS for the same period was $1.09, down from $1.29 a year ago [1] - The reported revenue exceeded the Zacks Consensus Estimate of $1.42 billion, resulting in a surprise of +0.89% [1] - Clean Harbors delivered an EPS surprise of +6.86%, with the consensus EPS estimate being $1.02 [1] Revenue Breakdown - Environmental Services revenue was $1.21 billion, matching the average estimate from three analysts, representing a year-over-year increase of +3.1% [4] - Safety-Kleen Sustainability Solutions revenue was $222.74 million, exceeding the average estimate of $194.66 million, with a year-over-year change of +9.1% [4] - Corporate Items revenue was $0.10 million, consistent with the average estimate from two analysts, but down -4.9% compared to the year-ago quarter [4] Adjusted EBITDA Performance - Adjusted EBITDA for Environmental Services was $274.59 million, slightly above the estimate of $273.41 million from three analysts [4] - Adjusted EBITDA for Corporate Items was -$67.99 million, compared to the average estimate of -$66.52 million from three analysts [4] - Adjusted EBITDA for Safety-Kleen Sustainability Solutions was $28.25 million, surpassing the estimate of $22.88 million from three analysts [4] Stock Performance - Clean Harbors shares returned +6.6% over the past month, while the Zacks S&P 500 composite experienced a -0.2% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]

Financial Performance - Sales and Revenues decreased by $1550 million, a 10% decrease, from $15799 million in 1Q 2024 to $14249 million in 1Q 2025[23, 24] - Operating Profit decreased by $940 million, a 27% decrease, from $3519 million in 1Q 2024 to $2579 million in 1Q 2025[27, 28, 29] - Adjusted Profit per Share decreased from $560 in 1Q 2024 to $425 in 1Q 2025[10, 19] - ME&T Free Cash Flow for 1Q 2025 was $02 billion, a decrease compared to 1Q 2024, primarily driven by lower profit[13, 14, 47, 48] Segment Performance - Construction Industries total sales decreased by $1240 million, a 19% decrease, and segment profit decreased by $740 million, a 42% decrease[32, 33] - Resource Industries total sales decreased by $309 million, a 10% decrease, and segment profit decreased by $131 million, an 18% decrease[35, 36] - Energy & Transportation total sales decreased by $113 million, a 2% decrease, while segment profit increased by $13 million, a 1% increase[38, 39, 40] - Financial Products total revenues increased by $16 million, a 2% increase, while segment profit decreased by $78 million, a 27% decrease[42, 43, 44] Future Outlook - The company expects 2025 full-year sales and revenues to be about flat compared to 2024, an improvement from previous expectations of a slight decrease[51] - The company expects 2Q 2025 sales and revenues to be similar to 2Q 2024[52]

Core Insights - SoFi Technologies reported its first-quarter earnings, highlighting key management comments during the earnings call [1] Financial Performance - The earnings report includes specific financial metrics and performance indicators that reflect the company's growth and operational efficiency [1] Management Commentary - Management provided insights into strategic initiatives and future outlook during the earnings call, emphasizing areas of focus for continued growth [1]

Core Insights - CoStar Group reported revenue of $732.2 million for the quarter ended March 2025, reflecting an 11.6% increase year-over-year and exceeding the Zacks Consensus Estimate of $719.37 million by 1.78% [1] - The company's EPS was $0.14, up from $0.10 in the same quarter last year, representing a surprise of 27.27% compared to the consensus estimate of $0.11 [1] Revenue Breakdown - CoStar's revenue from its core business was $265.10 million, slightly above the average estimate of $264.81 million, marking a year-over-year increase of 5.9% [4] - Information Services generated $39.80 million, exceeding the estimated $36.30 million, with a year-over-year growth of 20.6% [4] - Other Marketplaces reported $44.80 million, significantly higher than the estimated $29.55 million, showing a year-over-year increase of 46.4% [4] - LoopNet's revenue was $72.80 million, slightly below the estimate of $73.38 million, with a year-over-year growth of 5.4% [4] - Residential revenue reached $27.20 million, below the estimate of $28.70 million, but still reflecting a substantial year-over-year increase of 46.2% [4] - Multifamily revenue was $282.50 million, close to the estimate of $283.47 million, with a year-over-year growth of 10.9% [4] Stock Performance - CoStar's shares have returned 3.2% over the past month, outperforming the Zacks S&P 500 composite, which declined by 0.8% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market in the near term [3]

Core Insights - UMB Financial (UMBF) reported a revenue of $571.34 million for Q1 2025, marking a 41% year-over-year increase and exceeding the Zacks Consensus Estimate by 2.99% [1] - The earnings per share (EPS) for the same quarter was $2.58, up from $2.47 a year ago, representing a surprise of 16.74% over the consensus estimate of $2.21 [1] Financial Performance Metrics - Efficiency Ratio (GAAP) was reported at 65.2%, higher than the average estimate of 59.5% from four analysts [4] - Net interest margin (FTE) stood at 3%, slightly above the average estimate of 2.9% from four analysts [4] - Net loan charge-offs as a percentage of total average loans were 0.5%, exceeding the average estimate of 0.2% from three analysts [4] - Average balance of total earning assets was $55.54 billion, surpassing the average estimate of $53.50 billion from three analysts [4] - Tier 1 risk-based capital ratio was reported at 10.4%, above the average estimate of 9.6% from two analysts [4] - Tier 1 Leverage Ratio was 8.5%, compared to the estimated 8.1% from two analysts [4] - Total Risk-based Capital Ratio was 12.5%, exceeding the average estimate of 11.6% from two analysts [4] - Net interest income (FTE) was $405.14 million, higher than the average estimate of $381.93 million from four analysts [4] - Total noninterest income was $166.20 million, below the average estimate of $177.22 million from four analysts [4] - Bankcard fees reached $26.29 million, exceeding the average estimate of $21.50 million from three analysts [4] - Service charges on deposit accounts were $27.46 million, lower than the average estimate of $32.17 million from three analysts [4] - Trust and securities processing income was $79.78 million, slightly above the average estimate of $79.38 million from three analysts [4] Stock Performance - UMB shares have returned -5.1% over the past month, compared to a -0.8% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the broader market in the near term [3]

Financial Performance - Total revenue for Q2 2025 was $498.7 million, a 13% increase quarter-over-quarter (Q/Q) and a 15% increase year-over-year (Y/Y) [3] - Scores revenue reached $297.0 million in Q2 2025, showing a 26% increase Q/Q and a 25% increase Y/Y [3] - Software revenue was $201.7 million in Q2 2025, a 1% decrease Q/Q but a 2% increase Y/Y [3] - Adjusted EBITDA for Q2 2025 was $287.8 million, a 29% increase Q/Q and a 22% increase Y/Y [3] - Non-GAAP diluted EPS was $7.81 in Q2 2025, a 35% increase Q/Q and a 27% increase Y/Y [3] Software Metrics - Software ARR (Annual Recurring Revenue) was $714.6 million, a 2% decrease Q/Q but a 3% increase Y/Y [3] - Software ACV (Annual Contract Value) Bookings were $21.8 million, a 3% increase Q/Q and a 30% increase Y/Y [3] - Platform ARR reached $234.7 million by March 31, 2025, representing 33% of the total ARR [17] - Non-Platform ARR reached $479.9 million by March 31, 2025, representing 67% of the total ARR [17] Scores Segment Highlights - Total Scores revenues increased by 25% compared to Q2 2024 [15] - B2B revenue increased by 31% compared to Q2 2024 [15] - Mortgage Originations revenues increased by 48% compared to Q2 2024 [15]